Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 February 2022 | Story Lacea Loader | Photo Sonia Small (Kaleidoscope Studios)
Dr Engela van Staden
Dr Engela van Staden, Vice Rector: Academic

The University of the Free State (UFS) has finalised the first part of the Council on Higher Education (CHE) Institutional Audit (IA), submitting its Institutional Self-Evaluation Report (SER) and Portfolio of Evidence (PoE) to the higher education quality assurance body. 

According to Dr Engela van Staden, Vice-Rector: Academic, the second part of the institutional audit will involve the participation of relevant stakeholders in a site visit to the institution. During the visit, scheduled between 9 and 13 May 2022, an external panel of experts will systematically assess the submitted SER and requisite documents by asking inquisitive questions to interviewees who will be participating in this process.  

“The focus will be on the quality of programme offerings with a view to improving student success in all spheres of the student walk – from registration to graduation. To this end, the university’s Integrated Quality Management Framework (IQMF) will be assessed in order to provide evidence that quality assurance is ingrained in the core functions of the UFS, i.e., student success; quality of teaching and research; and engaged scholarship.”

Dr Van Staden says by re-introducing the SER, the university will embark on a stakeholder engagement plan, engaging with staff in faculties, service units, directorates, centres, departments, or schools, to keep them informed and prepared for a productive contribution to the Institutional Audit process. 

- The CHE is an independent statutory body established in terms of the provisions of the Higher Education Act No. 101 of 1997, as amended. It advises the Minister responsible for Higher Education and Training and is the national authority for quality assurance and promotion in higher education.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept